He, Z., Chen, D., Li, L., Li, S., Song, F., Cai, J., . . . Xu, J. (2025). TTLL4 mediates the PI3K/AKT/MDM2 pathway to promote hepatocellular carcinoma progression and predict patient prognosis. AIP Publishing LLC.
Chicago Style (17th ed.) CitationHe, Zeping, et al. TTLL4 Mediates the PI3K/AKT/MDM2 Pathway to Promote Hepatocellular Carcinoma Progression and Predict Patient Prognosis. AIP Publishing LLC, 2025.
MLA (9th ed.) CitationHe, Zeping, et al. TTLL4 Mediates the PI3K/AKT/MDM2 Pathway to Promote Hepatocellular Carcinoma Progression and Predict Patient Prognosis. AIP Publishing LLC, 2025.
Warning: These citations may not always be 100% accurate.